European Patent Office grants new CRISPR/Cas9 patent (EP 4 289 948) to CVC, with broad claims covering guide RNAs and their combination with Cas9. Patent strengthens CVC’s leading position in European CRISPR IP landscape, providing security to over 150 ERS Genomics licensees. DUBLIN, IRELAND and CHESHIRE, UK – ERS Genomics (‘ERS’), which was established to provide [...]

BOULDER, CO – Watchmaker Genomics, a leading provider of precision tools for genomic research and clinical applications, today announced the successful completion of a key milestone under its TAPS (TET-assisted pyridine borane sequencing) Technology License and Supply Alliance¹ with Exact Sciences. This progress underscores Watchmaker’s commitment to commercializing TAPS, a transformative epigenetic analysis technology for high-accuracy genomic [...]

Gene structure information identified by combining Compugen's AI/ML predictive computational discovery platform, Unigen™ with Ultima's UG 100™ sequencing platform to better understand tumor biology and immune regulation Leveraging Compugen's computational analytical tools uncovered high consistency in single-cell expression levels across Ultima's UG 100 sequencing platform, offering a potential advantage for demarcation of transcript termination. Research presented at [...]

Beverly, MA – As the market leader in laboratory automation, HighRes Biosolutions has long empowered pharmaceutical companies and top research institutes to automate high-throughput drug discovery, genomics, and synthetic biology workflows. Now, the company is setting its sights on the next frontier, enabling seamless orchestration of whole lab workflows and standardizing the way in which experimental [...]

Accelerates Solventum's business transformation and sharpens focus on strategic areas for growth to deliver long-term shareholder value Strengthens balance sheet with proceeds to be used primarily for debt paydown ST. PAUL, Minn. -- Solventum (NYSE: SOLV) today announced it has entered into a definitive agreement to sell its Purification & Filtration1 business to Thermo Fisher Scientific Inc. [...]

The Pixelgen Proxiome Kit offers the next omics dimension for single cells, protein interactomics Stockholm, Sweden and Marco Island, Fla. – Pixelgen Technologies today unveiled a novel technology for exploring the dynamic protein interactome at the single cell level, building on its earlier technological innovations in DNA-based 3D proteomics. The Proximity Network Assay delivers nanoscale spatial analysis of [...]

Accelerates Solventum's business transformation and sharpens focus on strategic areas for growth to deliver long-term shareholder value Strengthens balance sheet with proceeds to be used primarily for debt paydown ST. PAUL, Minn. -- Solventum (NYSE: SOLV) today announced it has entered into a definitive agreement to sell its Purification & Filtration1 business to Thermo Fisher Scientific Inc. [...]

Smart Subtract® enhances chromatographic subtraction, making GC–MS and GC×GC–MS data comparisons faster and more intuitive. Reduces analysis time from days to minutes by automating the identification of key differences between complex chromatograms. Designed for seamless integration into existing workflows, ensuring precise, user-friendly results without the need for statistical expertise. SepSolve Analytical Ltd (Peterborough, UK) has launched Smart [...]

Unlocking High-Sensitivity Structural Variant Detection and RNA Profiling for Cancer Research SCOTTS VALLEY, Calif. -- Dovetail Genomics, a leading innovator in genomic solutions, today announces the availability of its early access services for FFPE (Formalin-Fixed Paraffin-Embedded) sample analysis, offering new capabilities for detecting structural variants and profiling RNA in oncology research. This service includes the detection of [...]

Highly Complementary to Thermo Fisher’s Bioproduction Business and Strengthens Offering in the High Growth Bioprocessing Market WALTHAM, Mass. -- Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that the company has entered into a definitive agreement with Solventum (NYSE: SOLV) to acquire Solventum’s Purification & Filtration business [...]